PSYCHIATRIC TREATMENT AND OUTCOMES OF MEDICARE PATIENTS

医疗保险患者的精神治疗和结果

• 批准号: 2253917
• 负责人: SUSAN Louise ETTNER
• 金额: $ 17.4万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2253917
• 关键词: Medicare /Medicaid; comprehensive care; electroconvulsive therapy; health care cost /financing; health care policy; health care service availability; health care service evaluation; health care service utilization; health economics; hospital analysis; hospital length of stay; hospital utilization; hospitals; human data; human old age (65+); human population study; mathematical model; mental disorder chemotherapy; mental health facility; mental health personnel; mental health services; psychiatric patient care; psychosis; psychotherapy; socioeconomics

This FIRST award (R29) project will examine sources of variation in treatment patterns, costs and utilization-based outcomes among elderly and disabled Medicare beneficiaries suffering from psychiatric disease. Aim 1 is to determine how the availability of mental health resources, other regulatory and financing factors and patient characteristics influence treatment patterns among Medicare patients receiving mental health services. Treatment setting, facility type and therapy option will be examined. Aim 2 is to compare the outcomes and costs of Medicare patients who experience different patterns of psychiatric treatment, using econometric techniques to control for selection into different treatments. Outcomes examined will include continuity of care, rehospitalization, length of hospital stay and discharge status. Aim 3 is to examine how provider characteristics and market structure influence treatment patterns, costs and outcomes. Provider characteristics considered will include facility ownership, profit status, size and teaching status. Aim 4 is to examine how patient characteristics and the availability of psychiatric services affect unmet needs among persons in need of mental health services. This analysis will allow us to establish whether the elderly are an underserved population with respect to psychiatric treatment and will enable us to determine the nature of the selection bias from restricting analyses to the treated population only. The analyses of Aims 1-3 will rely primarily on Medicare data, along with several other secondary databases. Aim 4 will use diagnostic and treatment information from the 1996 National Health Interview Survey.

这个第一个奖项（R29）项目将检查差异来源 老年人和基于利用的治疗模式，成本和基于利用的结果 患有精神病的残疾医疗保险受益人。 目的 1是确定心理健康资源的可用性，其他 监管和融资因素以及患者特征影响 接受心理健康的Medicare患者的治疗模式 服务。 治疗环境，设施类型和治疗选择将是 检查。 AIM 2是比较Medicare患者的结果和成本 谁经历了不同的精神病治疗方式 计量经济学技术以控制选择不同的治疗方法。 所检查的结果将包括护理的连续性，重新寄养， 住院时间和出院状态。目标3是检查如何 提供者特征和市场结构影响治疗 模式，成本和结果。考虑的提供者特征将 包括设施所有权，利润状况，规模和教学状态。 目的 4是检查患者特征和可用性 精神科服务会影响需要精神的人的未满足需求 卫生服务。 这种分析将使我们能够确定是否 老年人在精神病学方面是服务不足的人口 治疗并将使我们能够确定选择偏差的性质 从限制分析到治疗人群。 分析 AIMS 1-3主要依靠Medicare数据以及其他几个 次要数据库。 AIM 4将使用诊断和治疗信息 从1996年的国家健康访谈调查中。